- Home
- CNTB vs ATLX Comparison
CNTB vs ATLX Comparison
Compare CNTB & ATLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- ATLX
- Stock Information
- Founded
- CNTB 2012
- ATLX 2011
- Country
- CNTB United States
- ATLX Brazil
- Employees
- CNTB N/A
- ATLX N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- ATLX Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- Sector
- CNTB Health Care
- ATLX Industrials
- Exchange
- CNTB Nasdaq
- ATLX Nasdaq
- Market Cap
- CNTB 114.8M
- ATLX 95.1M
- IPO Year
- CNTB 2021
- ATLX N/A
- Fundamental
- Price
- CNTB $1.60
- ATLX $4.59
- Analyst Decision
- CNTB Strong Buy
- ATLX Strong Buy
- Analyst Count
- CNTB 2
- ATLX 1
- Target Price
- CNTB $7.50
- ATLX $19.00
- AVG Volume (30 Days)
- CNTB 156.9K
- ATLX 413.0K
- Earning Date
- CNTB 09-05-2025
- ATLX 11-07-2025
- Dividend Yield
- CNTB N/A
- ATLX N/A
- EPS Growth
- CNTB N/A
- ATLX N/A
- EPS
- CNTB N/A
- ATLX N/A
- Revenue
- CNTB $1,965,000.00
- ATLX $350,003.00
- Revenue This Year
- CNTB N/A
- ATLX $22,084.55
- Revenue Next Year
- CNTB N/A
- ATLX N/A
- P/E Ratio
- CNTB N/A
- ATLX N/A
- Revenue Growth
- CNTB N/A
- ATLX N/A
- 52 Week Low
- CNTB $1.55
- ATLX $3.54
- 52 Week High
- CNTB $2.20
- ATLX $11.89
- Technical
- Relative Strength Index (RSI)
- CNTB 42.21
- ATLX 43.25
- Support Level
- CNTB $1.55
- ATLX $4.57
- Resistance Level
- CNTB $1.76
- ATLX $4.96
- Average True Range (ATR)
- CNTB 0.18
- ATLX 0.33
- MACD
- CNTB -0.03
- ATLX -0.07
- Stochastic Oscillator
- CNTB 9.92
- ATLX 16.51
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About ATLX Atlas Lithium Corporation
Atlas Lithium Corp is a mineral exploration and development company with lithium projects and exploration properties in other critical and battery minerals, including nickel, rare earth, graphite, and titanium, to power the increased demand for electrification. Its focus is on developing its hard-rock lithium project Minas Gerais Lithium Project located in Minas Gerais State in Brazil. The company intends to produce and sell lithium concentrate, a key ingredient for the battery supply chain. It intends to mine and then process its lithium-containing ore to produce lithium concentrate (also known as spodumene concentrate), a key ingredient for the battery supply chain.